|
SSB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.359800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.130980E-01 |
| Normal-vs-Stage2 |
4.604000E-02 |
| Normal-vs-Stage3 |
4.759900E-03 |
| Normal-vs-Stage4 |
9.042400E-03 |
| Stage1-vs-Stage2 |
2.027400E-01 |
| Stage1-vs-Stage3 |
8.439900E-02 |
| Stage1-vs-Stage4 |
1.221200E-01 |
| Stage2-vs-Stage3 |
9.625800E-01 |
| Stage2-vs-Stage4 |
8.898000E-01 |
| Stage3-vs-Stage4 |
8.147600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.061910E-02 |
| Normal-vs-AfricanAmerican |
5.056600E-01 |
| Normal-vs-Asian |
8.863000E-01 |
| Caucasian-vs-AfricanAmerican |
4.081400E-01 |
| Caucasian-vs-Asian |
8.272300E-02 |
| AfricanAmerican-vs-Asian |
6.795200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.209980E-02 |
| Normal-vs-Female |
2.789900E-02 |
| Male-vs-Female |
4.346400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.275420E-01 |
| Normal-vs-Age(41-60Yrs) |
7.617900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.719700E-03 |
| Normal-vs-Age(81-100Yrs) |
6.382500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.887390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.620400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.836400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.411800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.565200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.470600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.392610E-01 |
| Classical-VS-Follicular |
5.442200E-01 |
| Classical-VS-Other |
5.806600E-01 |
| Classical-VS-Normal |
8.810300E-02 |
| Tall-VS-Follicular |
3.865800E-01 |
| Tall-VS-Other |
8.312000E-01 |
| Tall-VS-Normal |
7.643000E-03 |
| Follicular-VS-Other |
8.404400E-01 |
| Follicular-VS-Normal |
9.413500E-02 |
| Other-VS-Normal |
2.034600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.948050E-02 |
| Normal-vs-N1 |
9.796000E-02 |
| N0-vs-N1 |
9.279000E-01 |
|
|
